Access decision-making in the Belgian Commission for reimbursement of medicines 2010-2017: Investigating the readiness for value-based pricing
Van Dyck, Walter Schoonaert, Lies Geldof, Tine Govaerts, Laurenz
Van Dyck, Walter
Schoonaert, Lies
Geldof, Tine
Govaerts, Laurenz
Citations
Altmetric:
Publication Type
Policy paper
Editor
Supervisor
Publication Year
2018
Journal
Book
Publication Volume
Publication Issue
Publication Begin page
Publication End page
Publication NUmber of pages
47
Collections
Abstract
To balance the societal need for affordability of medicines with the industrial need for sustained innovation, the present pharmaceutical technology supply-driven system needs to become a societal demand-driven system. Value-based pricing is considered to be a key component of such a system, next to the conditional dialogue between payer and industry we proposed in previous work (Van Dyck, De Grève et al. 2016) in which it should be embedded. To find out how far Belgian pharmaceutical healthcare-related decision-making has evolved within this paradigm, we empirically investigated the access and reimbursement decision-making of the Belgian Commission for Reimbursement of Medicines (CRM) for the period 2010 – 2017. We combined this investigation with previous work in a meta-analysis in order to have the most complete picture possible of the present factors influencing decision-making in the Belgian system.
Research Projects
Organizational Units
Journal Issue
Keywords
Healthcare